Clinical Trial Update: Influence of BCG on TDaP-IPV Vaccination [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether BCG vaccination alters the immune response to Tdap-IPV vaccination for pertussis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)
• Tdap-IPV vaccine (Tetanus toxoid, diphtheria toxoid, acellular pertussis vaccine, inactivated poliovirus vaccine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Whooping Cough | Phase 4 | Status: UNKNOWN